CAMP4 THERAPEUTICS CORPORATION

8-K Regulation FD disclosure; Other events Jul 27, 2026 8-K Director or officer change; Shareholder vote results Jun 12, 2026 8-K Regulation FD disclosure May 14, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Results of operations (earnings release) May 7, 2026 8-K Director or officer change Mar 24, 2026 10-K Fiscal year ended 2025-12-31 Mar 5, 2026 8-K Completed an acquisition or disposition; Regulation FD disclosure Mar 5, 2026 8-K Regulation FD disclosure Jan 9, 2026 8-K Entered a material agreement; Terminated a material agreement Dec 23, 2025 8-K Entered a material agreement Dec 18, 2025 8-K Entered a material agreement; Regulation FD disclosure Dec 18, 2025 10-Q Quarter ended 2025-09-30 Nov 6, 2025 8-K Results of operations (earnings release) Nov 6, 2025 8-K Regulation FD disclosure Oct 1, 2025 8-K Entered a material agreement; Unregistered sale of equity; Director or officer change; Regulation FD disclosure Sep 10, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 8-K Results of operations (earnings release) Aug 14, 2025 8-K Shareholder vote results Jun 13, 2025 8-K Regulation FD disclosure May 16, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 8-K Results of operations (earnings release) May 13, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Results of operations (earnings release) Mar 27, 2025 8-K Director or officer change Mar 18, 2025 8-K Regulation FD disclosure; Other events Jan 7, 2025 10-Q Quarter ended 2024-09-30 Nov 21, 2024 8-K Results of operations (earnings release) Nov 21, 2024 8-K Amended charter or bylaws Oct 15, 2024 4 FORM 4 Jun 12, 2026 4 FORM 4 Jun 12, 2026 4 FORM 4 Jun 12, 2026 4 FORM 4 Jun 12, 2026 4 FORM 4 Jun 12, 2026 4 FORM 4 Jun 12, 2026 SCHEDULE 13G May 15, 2026 ARS Apr 23, 2026 DEFA14A Apr 23, 2026 DEF 14A Apr 23, 2026 4 FORM 4 Apr 3, 2026